US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Peridot Acquisition Corp

11.23

0.0000

Volume:- -

Turnover:- -

Market Cap:421.13M

PE:-363.14

High:11.23

Open:11.23

Low:11.23

Close:11.23

Loading ...

Overview Company News Filings

Purple Biotech Announces First Patient Dosed in Open Label, Randomized Part of CM24 Phase 2 Clinical Trial

Canpipe Exhibiting at Booth 6526N, PDAC 2023 Convention in Toronto, March 5-8

Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer

Investor Opportunity to Meet Forum Energy Metals Management at The VRIC & PDAC Convention

Qualigen Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for QN-302, a G-Quadruplex (G4) Transcription Inhibitor for the Intended Indication of Pancreatic Cancer

BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer

Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments

BioLineRx to Participate in the 12th Annual LifeSci Partners Corporate Access Event

PDAC 2023 Awards Recognize Five Outstanding Industry Leaders

BioLineRx to Report Third Quarter 2022 Results on November 15, 2022

Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort

Purple Biotech to Present at the Jefferies London Healthcare Conference

Purple Biotech Reports Third Quarter 2022 Financial Results

Oncolytics Biotech® Reports Interim Results from Phase 1/2 GOBLET Study Showing a 70% Objective Response Rate in Pancreatic Cancer at the SITC Annual Meeting

Purple Biotech Appoints Lior Fhima as Chief Financial Officer

Press Release: Third Quarter Update 2022

BMF-219 Enters the Clinic for KRAS Solid Tumors

Press Release: RadioMedix announces a $40 million Series A financing for the advancement of novel Targeted Alpha Therapy platform and diagnostic companion radiopharmaceuticals to address unmet needs in oncology; Michael Lee-Chin appointed to the board of the company

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PDAC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDAC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDAC\",,,,,undefined,":{"symbol":"PDAC","market":"US","secType":"STK","nameCN":"Peridot Acquisition Corp","latestPrice":11.23,"timestamp":1628625600000,"preClose":11.23,"halted":8,"volume":0,"delay":0,"floatShares":25847265,"shares":37500000,"eps":-0.030925,"marketStatus":"Closed","change":0,"latestTime":"08-10 16:00:00 EDT","open":11.23,"high":11.23,"low":11.23,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.030925,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753084800000},"marketStatusCode":5,"symbolChange":{"newSymbol":"LICY","executeDate":"2021-08-11"},"adr":0,"exchange":"NYSE","adjPreClose":11.23,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDAC\",,,,,undefined,":{"symbol":"PDAC","floatShares":25847265,"roa":"--","roe":"--","lyrEps":-0.012885,"shares":37500000,"dividePrice":0,"high":11.23,"amplitude":0,"preClose":11.23,"low":11.23,"week52Low":8.81,"pbRate":"84.22","week52High":15.74,"institutionHeld":0,"latestPrice":11.23,"eps":-0.030925,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.030925,"open":11.23},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDAC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2311072161","title":"Purple Biotech Announces First Patient Dosed in Open Label, Randomized Part of CM24 Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2311072161","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2311072161?lang=en_us&edition=fundamental","pubTime":"2023-02-14 20:01","pubTimestamp":1676376060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ohrnykmVnVIZb2AQNAGEuA--~B/aD0xMzE2O3c9MTU3OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c7ebdce3e834000f67af0af16adacb53","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ohrnykmVnVIZb2AQNAGEuA--~B/aD0xMzE2O3c9MTU3OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c7ebdce3e834000f67af0af16adacb53"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/purple-biotech-announces-first-patient-120100859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CRC","PDAC","BK4007","PPBT","BK4213"],"gpt_icon":0},{"id":"2311973687","title":"Canpipe Exhibiting at Booth 6526N, PDAC 2023 Convention in Toronto, March 5-8","url":"https://stock-news.laohu8.com/highlight/detail?id=2311973687","media":"StreetInsider","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2311973687?lang=en_us&edition=fundamental","pubTime":"2023-02-13 20:38","pubTimestamp":1676291880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=21204606","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["PDAC"],"gpt_icon":0},{"id":"2308408670","title":"Purple Biotech Expands Pipeline of First-in-Class Therapeutics with Acquisition of Immunorizon and Its Portfolio of Tri-Specific Antibodies for the Treatment of Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2308408670","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2308408670?lang=en_us&edition=fundamental","pubTime":"2023-02-02 20:00","pubTimestamp":1675339200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ohrnykmVnVIZb2AQNAGEuA--~B/aD0xMzE2O3c9MTU3OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c7ebdce3e834000f67af0af16adacb53","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ohrnykmVnVIZb2AQNAGEuA--~B/aD0xMzE2O3c9MTU3OTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/c7ebdce3e834000f67af0af16adacb53"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/purple-biotech-expands-pipeline-first-120000897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PDAC","BK4007","PPBT","NK"],"gpt_icon":0},{"id":"2306479431","title":"Investor Opportunity to Meet Forum Energy Metals Management at The VRIC & PDAC Convention","url":"https://stock-news.laohu8.com/highlight/detail?id=2306479431","media":"StreetInsider","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2306479431?lang=en_us&edition=fundamental","pubTime":"2023-01-27 21:32","pubTimestamp":1674826320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=21123334","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["FET","BK4179","PDAC"],"gpt_icon":0},{"id":"2302510060","title":"Qualigen Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for QN-302, a G-Quadruplex (G4) Transcription Inhibitor for the Intended Indication of Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2302510060","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2302510060?lang=en_us&edition=fundamental","pubTime":"2023-01-10 22:00","pubTimestamp":1673359200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4njrwpEGJUU9fDyFjBOC_A--~B/aD05NzM7dz0xNjIxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ec0dc07765ff0e9ce31be1a8d4b30ed2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4njrwpEGJUU9fDyFjBOC_A--~B/aD05NzM7dz0xNjIxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/ec0dc07765ff0e9ce31be1a8d4b30ed2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qualigen-therapeutics-receives-orphan-drug-140000385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4191","CRCT","PDAC","BK4539","QLGN","TERN","BK4007"],"gpt_icon":0},{"id":"2300094421","title":"BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2300094421","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300094421?lang=en_us&edition=fundamental","pubTime":"2023-01-04 20:00","pubTimestamp":1672833600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/v03No7l4TmPeyhLm94mD1Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/89551d640191665d6c0daf40090be07c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/v03No7l4TmPeyhLm94mD1Q--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/89551d640191665d6c0daf40090be07c"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biolinerx-appoints-tami-rachmilewitz-m-120000173.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biolinerx-appoints-tami-rachmilewitz-m-120000173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BLRX","PDAC"],"gpt_icon":0},{"id":"2300045347","title":"Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2300045347","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2300045347?lang=en_us&edition=fundamental","pubTime":"2023-01-03 12:00","pubTimestamp":1672718400,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2023/01/03/2582013/0/en/Purple-Biotech-and-Mor-Research-Applications-Announce-Research-Collaboration-to-Identify-Promising-Investigational-Oncology-Treatments.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDAC"],"gpt_icon":0},{"id":"2287951715","title":"BioLineRx to Participate in the 12th Annual LifeSci Partners Corporate Access Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2287951715","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2287951715?lang=en_us&edition=fundamental","pubTime":"2022-11-29 05:30","pubTimestamp":1669671000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xm1ypYX53DSKIj6YdigW8g--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/e432b2545db3c253f832b10b77459d63","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xm1ypYX53DSKIj6YdigW8g--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/e432b2545db3c253f832b10b77459d63"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biolinerx-participate-12th-annual-lifesci-213000026.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biolinerx-participate-12th-annual-lifesci-213000026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PDAC","BLRX","BK4139"],"gpt_icon":0},{"id":"2285842962","title":"PDAC 2023 Awards Recognize Five Outstanding Industry Leaders","url":"https://stock-news.laohu8.com/highlight/detail?id=2285842962","media":"Financial Post","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2285842962?lang=en_us&edition=fundamental","pubTime":"2022-11-24 00:02","pubTimestamp":1669219333,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"redbox_crawler","url":"https://news.google.com/__i/rss/rd/articles/CBMiZWh0dHBzOi8vZmluYW5jaWFscG9zdC5jb20vZ2xvYmUtbmV3c3dpcmUvcGRhYy0yMDIzLWF3YXJkcy1yZWNvZ25pemUtZml2ZS1vdXRzdGFuZGluZy1pbmR1c3RyeS1sZWFkZXJz0gEA?oc=5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://news.google.com/__i/rss/rd/articles/CBMiZWh0dHBzOi8vZmluYW5jaWFscG9zdC5jb20vZ2xvYmUtbmV3c3dpcmUvcGRhYy0yMDIzLWF3YXJkcy1yZWNvZ25pemUtZml2ZS1vdXRzdGFuZGluZy1pbmR1c3RyeS1sZWFkZXJz0gEA?oc=5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"redbox_crawler","symbols":["PDAC"],"gpt_icon":0},{"id":"2282664145","title":"BioLineRx to Report Third Quarter 2022 Results on November 15, 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2282664145","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2282664145?lang=en_us&edition=fundamental","pubTime":"2022-11-11 05:30","pubTimestamp":1668115800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1B6lw3j2BVmrEnfhJGgQOA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0f69d6c4e971c33eff5925042ec64210","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1B6lw3j2BVmrEnfhJGgQOA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0f69d6c4e971c33eff5925042ec64210"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biolinerx-report-third-quarter-2022-213000331.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biolinerx-report-third-quarter-2022-213000331.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BLRX","PDAC","BK4139"],"gpt_icon":0},{"id":"2282619290","title":"Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2282619290","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2282619290?lang=en_us&edition=fundamental","pubTime":"2022-11-10 22:01","pubTimestamp":1668088860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/V4HsdfDOffpXrk.cqSWj5Q--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6f3fee9112cd498f5706afb24313777e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/V4HsdfDOffpXrk.cqSWj5Q--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6f3fee9112cd498f5706afb24313777e"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/oncolytics-biotech-presents-updated-clinical-140100887.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-presents-updated-clinical-140100887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AIO","PDAC","CR","CBR","BK4007","LINK","BK4161","BK4539","TERN","CRCT","BK4139","BK4080","PR","BK4213","KOL","SITC","SD","BK4191","ONCY"],"gpt_icon":0},{"id":"2282196237","title":"Purple Biotech to Present at the Jefferies London Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2282196237","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2282196237?lang=en_us&edition=fundamental","pubTime":"2022-11-10 12:00","pubTimestamp":1668052800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2022/11/10/2553000/0/en/Purple-Biotech-to-Present-at-the-Jefferies-London-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDAC"],"gpt_icon":0},{"id":"2281941759","title":"Purple Biotech Reports Third Quarter 2022 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2281941759","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2281941759?lang=en_us&edition=fundamental","pubTime":"2022-11-08 12:53","pubTimestamp":1667883180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2022/11/08/2550833/0/en/Purple-Biotech-Reports-Third-Quarter-2022-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDAC"],"gpt_icon":0},{"id":"2281078806","title":"Oncolytics Biotech® Reports Interim Results from Phase 1/2 GOBLET Study Showing a 70% Objective Response Rate in Pancreatic Cancer at the SITC Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2281078806","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2281078806?lang=en_us&edition=fundamental","pubTime":"2022-11-07 21:01","pubTimestamp":1667826060,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/V4HsdfDOffpXrk.cqSWj5Q--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6f3fee9112cd498f5706afb24313777e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/V4HsdfDOffpXrk.cqSWj5Q--~B/aD0xNzQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/6f3fee9112cd498f5706afb24313777e"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/oncolytics-biotech-reports-interim-results-130100589.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncolytics-biotech-reports-interim-results-130100589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AIO","BK4539","L","SITC","BK4107","BK4080","BK4191","CRCT","ONCY","PDAC","BK4007","LINK","KOL","LU0053666078.USD","TERN","BK4139"],"gpt_icon":0},{"id":"2280304182","title":"Purple Biotech Appoints Lior Fhima as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2280304182","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2280304182?lang=en_us&edition=fundamental","pubTime":"2022-11-02 11:37","pubTimestamp":1667360220,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2022/11/02/2546389/0/en/Purple-Biotech-Appoints-Lior-Fhima-as-Chief-Financial-Officer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDAC"],"gpt_icon":0},{"id":"2278761445","title":"Press Release: Third Quarter Update 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2278761445","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2278761445?lang=en_us&edition=fundamental","pubTime":"2022-10-24 20:00","pubTimestamp":1666612800,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","BK4139","PDAC","BK4526","BK4548","BK4535","BK4168","BGNE","BK4505","MMSDF"],"gpt_icon":0},{"id":"2275341439","title":"BMF-219 Enters the Clinic for KRAS Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2275341439","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2275341439?lang=en_us&edition=fundamental","pubTime":"2022-10-14 21:00","pubTimestamp":1665752400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/k9cW8p_6P7nsY6MiwHeLpg--~B/aD04MTQ7dz0zMDU4O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/SjN7sW6KWrRbGV9yW2csuQ--~B/aD04MTQ7dz0zMDU4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b4671cf05b5be2ee4acb607d886beaf2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/k9cW8p_6P7nsY6MiwHeLpg--~B/aD04MTQ7dz0zMDU4O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/SjN7sW6KWrRbGV9yW2csuQ--~B/aD04MTQ7dz0zMDU4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b4671cf05b5be2ee4acb607d886beaf2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bmf-219-enters-clinic-kras-130000963.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IND","BK4539","CRC","PDAC","BMEA","BK4139","BK4213"],"gpt_icon":0},{"id":"2273392115","title":"Press Release: RadioMedix announces a $40 million Series A financing for the advancement of novel Targeted Alpha Therapy platform and diagnostic companion radiopharmaceuticals to address unmet needs in oncology; Michael Lee-Chin appointed to the board of the company","url":"https://stock-news.laohu8.com/highlight/detail?id=2273392115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2273392115?lang=en_us&edition=fundamental","pubTime":"2022-10-08 06:15","pubTimestamp":1665180900,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","CRCT","TM","PDAC","BK4007","BK4191","BK4022","BK4099","R","BK4555","TERN","BK4539","TAT"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDAC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-08-11","symbol":"PDAC","oldSymbol":"PDAC","defaultRemindTime":1628688600000,"newSymbol":"LICY","exchange":"NYSE","type":"symbolChange","dateTimestamp":1628654400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDAC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDAC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PDAC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PDAC","date":"2021-08-09","current":-7.031789,"percent":0.822222,"low":-442.60021,"twenty":-424.41116,"median":-8.076965,"eighty":-7.084709,"high":-6.317364,"avg":-202.530749,"sd":206.378195,"marketCap":398625000},"quantilePoints":[{"date":"2021-04-01","current":-430.474176,"twenty":-432.09098,"median":-428.048969,"eighty":-425.300402,"marketCap":399375000},{"date":"2021-04-09","current":-432.899383,"twenty":-432.899383,"median":-430.069975,"eighty":-425.300402,"marketCap":401625000},{"date":"2021-04-16","current":-435.728791,"twenty":-435.48627,"median":-432.899383,"eighty":-425.623763,"marketCap":404250000},{"date":"2021-04-23","current":-418.752344,"twenty":-435.48627,"median":-430.474176,"eighty":-425.300402,"marketCap":388500000},{"date":"2021-04-30","current":-413.49773,"twenty":-435.32459,"median":-427.644768,"eighty":-423.360237,"marketCap":383625000},{"date":"2021-05-07","current":-415.922937,"twenty":-434.839548,"median":-425.623763,"eighty":-418.752344,"marketCap":385875000},{"date":"2021-05-14","current":-405.009507,"twenty":-433.546105,"median":-424.815361,"eighty":-415.761257,"marketCap":375750000},{"date":"2021-05-21","current":-405.413708,"twenty":-432.899383,"median":-424.209059,"eighty":-413.65941,"marketCap":376125000},{"date":"2021-05-28","current":-405.413708,"twenty":-431.9293,"median":-419.560747,"eighty":-406.38379,"marketCap":376125000},{"date":"2021-06-04","current":-6.919333,"twenty":-430.393336,"median":-418.752344,"eighty":-405.494548,"marketCap":392250000},{"date":"2021-06-11","current":-7.633758,"twenty":-429.827454,"median":-416.933439,"eighty":-405.009507,"marketCap":432750000},{"date":"2021-06-18","current":-7.620528,"twenty":-428.372331,"median":-413.901931,"eighty":-7.74489,"marketCap":432000000},{"date":"2021-06-25","current":-7.759443,"twenty":-426.432165,"median":-413.49773,"eighty":-7.680063,"marketCap":439875000},{"date":"2021-07-02","current":-8.076965,"twenty":-425.623763,"median":-407.232613,"eighty":-7.732983,"marketCap":457875000},{"date":"2021-07-09","current":-7.891744,"twenty":-425.623763,"median":-406.02001,"eighty":-7.754151,"marketCap":447375000},{"date":"2021-07-16","current":-6.978869,"twenty":-424.977041,"median":-405.413708,"eighty":-7.672125,"marketCap":395625000},{"date":"2021-07-23","current":-6.912718,"twenty":-424.815361,"median":-405.211608,"eighty":-7.567607,"marketCap":391875000},{"date":"2021-07-30","current":-6.608426,"twenty":-424.815361,"median":-404.605306,"eighty":-7.399585,"marketCap":374625000},{"date":"2021-08-06","current":-7.117784,"twenty":-424.492,"median":-8.116656,"eighty":-7.111169,"marketCap":403500000},{"date":"2021-08-09","current":-7.031789,"twenty":-424.41116,"median":-8.076965,"eighty":-7.084709,"marketCap":398625000}],"updateTime":1752897254549}}}